Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
13F holders, Q3 2024 (September 30)3holders
0new positions
0sold out
$1.03avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Bridgebio Pharma Inc. (bbio 2.5 03/15/27) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were New York State Common Retirement Fund ($5.0M), Bank of New York Mellon Corp ($516K) and Choreo, LLC ($30K).
- Company
- Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
- CUSIP
- 10806XAB8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 1,852,000 shares bought, net +1,852,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| New York State Common Retirement Fund | 0.01% | Add +61.7% | 4,826,000 | $5.0M |
| Bank of New York Mellon Corp | 0.00% | No change | 500,000 | $516K |
| Choreo, LLC | 0.00% | Add +61.1% | 29,000 | $30K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.5 03/15/27) the manager owns.